Please use this identifier to cite or link to this item: https://dspace.ctu.edu.vn/jspui/handle/123456789/54670
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNguyễn, Văn Giang-
dc.contributor.authorNguyễn, Gia Anh Tuấn-
dc.contributor.authorNguyễn, Văn Hải-
dc.contributor.authorNguyễn, Đình Luyện-
dc.date.accessioned2021-06-09T07:49:06Z-
dc.date.available2021-06-09T07:49:06Z-
dc.date.issued2018-
dc.identifier.issn0866-7861-
dc.identifier.urihttps://dspace.ctu.edu.vn/jspui/handle/123456789/54670-
dc.description.abstractPazopanib hydrochloride, a tyrosine kinase inhibitor, was synthesized by combinating indazole 2 and 2,4-dichloropyrimidine and sulfonamide 3 inthe overall yield of 42.7%. The structure of the synthesized intermediates and final product were confirmed by IR, NMR and MS.vi_VN
dc.language.isovivi_VN
dc.relation.ispartofseriesTạp chí Dược học;Số 510 .- Tr.56-58-
dc.subjectIndazolevi_VN
dc.subjectSulfonamidevi_VN
dc.subjectPazopanib hydrochloridevi_VN
dc.subjectTyrosine kinasevi_VN
dc.titleNghiên cứu tổng hợp thuốc chống ung thư pazopanib hydroclorid. Phần II: Tổng hợp pazopanib hydroclorid từ 2,3-dimethyl-1H-indazol-6-amin ở quy mô phòng thí nghiệmvi_VN
dc.typeArticlevi_VN
Appears in Collections:Dược học

Files in This Item:
File Description SizeFormat 
_file_
  Restricted Access
2.44 MBAdobe PDF
Your IP: 18.119.118.151


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.